International scientific guideline: Points to consider on Non-Clinical Assessment of the Carcinogenic Potential of Insulin Analogues

About this guideline

Overseas effective date: 4 September 2002

Categories: Nonclinical | Toxicology | Carcinogenicity

Access this international scientific guideline

For more information see International scientific guidelines adopted in Australia.

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.